期刊文献+

下呼吸道感染患者痰培养和药敏结果分析 被引量:4

A study on bacterial spectrum and drug resistance in patients with lower respiratory tract infection
下载PDF
导出
摘要 目的调查近年来本院呼吸内科病房下呼吸道感染患者病原菌分布特点及对常用抗菌药物的敏感性和耐药性。方法下呼吸道感染患者1465痰标本行细菌培养,采用纸片扩散法(Kirby-Bauer法),按NCCLS标准判定敏感菌珠。结果分离出细菌410株,革兰阴性杆菌占68.05%;其中,排前几位的依次为铜绿假单胞菌、肺炎克雷白杆菌、鲍曼不动杆菌、大肠杆菌、阴沟肠杆菌;革兰阳性球菌占31.95%,其中以表皮葡萄球菌、金黄色葡萄球菌、肺炎链球菌为优势菌。革兰阴性杆菌对亚胺培南、头孢吡肟、丁胺卡那霉素、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦表现出较好的敏感性;革兰阳性球菌对万古霉素、哌拉西林/他唑巴坦、利福平、新诺明有较好的敏感性。结论住院患者下呼吸道感染以革兰阴性杆菌为主且多重耐药;临床上及时掌握病原菌及其耐药性的最新动态,合理使用抗生素及细菌耐药性的监测尤为重要。 Objective To study the bacterial characteristics, drug sensitivity and resistance of strains isolated irom patients with lower respiratory tract infection. Methods From 2004 to 2006,410 clinical isolates were acquired from phlegm specimens,and bacterial susceptibility test was carried out by Kirby-Bauer method according to NCCLS standards. Results Gram-negative rod was at 68.05% .Pseudomonas aerations,Klebsiella,Escherichia coli,Baumanii, Haemophilus influenzae,and Enterbacter cloacae were in the first place. Gram-positive cocci was at 31.95%. Pathogenic streptococci, Staphylococcus aureus,Streptococcus pneumoniae were in the first place. The most active agents against Gram negative organisms were tienam,cefepime,kanamycin and pipeacilline/tazobactam. Gram-positive coccis were sensitive to vancomycin,piperacillin,piperacillin/tazobactam. Conclusion Pathogens of patients with lower respiratory tract infection are mainly Gram negative organisms and they are multidrug-resistance;it is essential to pay more attention to the continuous surveillance of antimicrobial resistance in clinics and prevent transmission and epidemic of these resistance strains.It is very important to select antibiotics for the treatment of infection rationally.
出处 《云南医药》 CAS 2007年第6期524-526,共3页 Medicine and Pharmacy of Yunnan
关键词 细菌谱 耐药性 敏感性 下呼吸道感染 Bacterial spectrum Drug resistance Drug sensitivity Lower respiratory tract infection
  • 相关文献

参考文献4

二级参考文献27

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 3辛建文 白友华 等.下呼吸道感染患者痰菌分离谱和细菌耐药性变迁[J].实用肺科杂志,1997,4:24-27.
  • 4应妩 王毓三.全国临床检验操作规程[M](第2版)[M].北京:中华人民共和国卫生部医政司,1997.556.
  • 5National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing,Twelfth Informational Supplement[S]. 2003 ,M100-S13.
  • 6Jae-Hoon Song. Pneumococcal Resistance to Beta-Lactams and Macrolides[C]. International Symposium on Antimicrobial Agents and Resistance, 2003,30-33.
  • 7Center for diseases prevention &epidemiology. oregon health division. Vancomycin-resistant enterococcal infections[J]. C D summary, 1997,46:1.
  • 8EARSS Annual Report 2002[EB/OL]. http://www. earss.rivm. nl.
  • 9Wang H, KelKar S, Wu W, etal, Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases:prevalence of CTX-M-3 at a hospital in China[J]. Antimicrob Agents chemother, 2003,47: 790-793.
  • 10Chanawong A,MZali FH, Heritage J. et al. Three cefortaximases, CTX-M-9, CTX-M-13 and CTX-M-14, among Enterobacteriaceae in the People's Republic of China[J]. Antimicrob Agents Chemother, 2002,46: 630-637.

共引文献173

同被引文献24

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部